Other commenters requested that CMS delay the changes and conduct further analysis so that the public can evaluate them
S6.B: SPECIFIED STIMULANTS INCLUDING, BUT NOT LIMITED TO: 2-phenylpropan-1-amine (-methylphenylethylamine, BMPEA) 3-Methylhexan-2-amine (1,2-dimethylpentylamine) 4-Fluoromethylphenidate 4-Methylhexan-2-amine (1,3-dimethylamylamine, 1,3 DMAA, methylhexaneamine) 4-Methylpentan-2-amine (1,3-dimethylbutylamine) 5-Methylhexan-2-amine (1,4-dimethylamylamine, 1,4-dimethylpentylamine, 1,4-DMAA) Benzfetamine Cathine** Cathinone and its analogues, e.g
Since BPC-157 has not undergone clinical testing in humans, there is no established dosing, no safety profile and no information on potential long-term risks
Fr rzte gilt: Beratung zur Beschaffung kann als strafbare Beihilfe gewertet werden